Concomitant Phosphodiesterase 5 Inhibition Enhances Myocardial Protection by Inhaled Nitric Oxide in Ischemia-Reperfusion Injury.
about
Tadalafil, a long acting phosphodiesterase inhibitor, promotes bone marrow stem cell survival and their homing into ischemic myocardium for cardiac repair.Development of a portable mini-generator to safely produce nitric oxide for the treatment of infants with pulmonary hypertension.Relaxin: reproductive safeguard turned cardiac?cGMP at the centre of attention: emerging strategies for activating the cardioprotective PKG pathway.
P2860
Concomitant Phosphodiesterase 5 Inhibition Enhances Myocardial Protection by Inhaled Nitric Oxide in Ischemia-Reperfusion Injury.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
Concomitant Phosphodiesterase ...... n Ischemia-Reperfusion Injury.
@en
Concomitant Phosphodiesterase ...... n Ischemia-Reperfusion Injury.
@nl
type
label
Concomitant Phosphodiesterase ...... n Ischemia-Reperfusion Injury.
@en
Concomitant Phosphodiesterase ...... n Ischemia-Reperfusion Injury.
@nl
prefLabel
Concomitant Phosphodiesterase ...... n Ischemia-Reperfusion Injury.
@en
Concomitant Phosphodiesterase ...... n Ischemia-Reperfusion Injury.
@nl
P2093
P2860
P356
P1476
Concomitant Phosphodiesterase ...... n Ischemia-Reperfusion Injury.
@en
P2093
Bela Merkely
Ellen Caluwe
Hilde Gillijns
Melissa Swinnen
Stefan P Janssens
Zsolt Szelid
P2860
P304
P356
10.1124/JPET.115.227850
P407
P577
2015-11-30T00:00:00Z